Feraheme: Clinical Trials

8 trials of Feraheme, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 enrolling by invitation, 1 unknown, 1 withdrawn. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 5, Enrolling by invitation 1, Unknown 1, Withdrawn 1

Follow Feraheme: new trials by email Literature Review of Feraheme trials Research Report on Feraheme

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nanozymes in Endodontics
Nanozyme treatment, Control (Standard treatment) - Apical Periodontitis, Endodontic Disease
Phase 4Enrolling by invitationUniversity of Pennsylvania722026-08-242026-10-13
Predicting Stroke Risk in ICAD With Novel MRI
Feraheme - Intracranial Atherosclerosis
Phase 4WithdrawnNorthwestern University2020-09-012026-08-06
A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment
Iron oxide nanoparticles treatment Ferumoxytol/H2O2, NaOCl, NaCl - Apical Periodontitis, Pulp Disease, Dental
Phase 4CompletedUniversity of Pennsylvania442020-07-132024-08-28
IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding
Ferumoxytol, Ferrous Sulfate - Anemia, Iron Deficiency, Heavy Menstrual Bleeding
Phase 4UnknownThomas Jefferson University762020-02-142023-11-21
Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease
ferumoxytol, gadofosveset - Pediatric Congenital Heart Disease
Phase 4CompletedPaul Finn172016-04-012022-12-28
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
Ferumoxytol - Iron-Deficiency Anemia, Inflammation
Phase 4CompletedGeorges Ouellet152013-09-012015-04-13
Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
Ferumoxytol, Iron Sucrose - Iron Deficiency Anemia Treatment, Chronic Kidney Disease(CKD)
Phase 4CompletedAMAG Pharmaceuticals, Inc.2962013-08-012022-04-21
Iron Indices and Intravenous Ferumoxytol: Time to Steady State
ferumoxytol - Iron Deficiency Anemia
Phase 4CompletedDialysis Clinic, Inc.152010-03-012012-03-30

Conditions studied

Anemia, Iron-Deficiency (4)  ·  Dental Pulp Diseases (2)  ·  Periapical Periodontitis (2)  ·  Renal Insufficiency, Chronic (2)  ·  Anemia (1)  ·  Constriction, Pathologic (1)  ·  Inflammation (1)  ·  Intracranial Arteriosclerosis (1)  ·  Menorrhagia (1)  ·  Plaque, Amyloid (1)  ·  Stroke (1)

Sponsors

University of Pennsylvania (2)  ·  AMAG Pharmaceuticals, Inc. (1)  ·  Dialysis Clinic, Inc. (1)  ·  Georges Ouellet (1)  ·  Northwestern University (1)  ·  Paul Finn (1)  ·  Thomas Jefferson University (1)

Countries

United States (7)  ·  Canada (2)  ·  United Kingdom (1)

Top investigators

Bekir Karabucak, DMD, MS (1)  ·  Georges Ouellet, MD (1)  ·  Sameer A Ansari, MD, PhD (1)  ·  Toros Kapoian, MD (1)

Results publications

PMID 28372549, PMID 30802204